{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:26:08Z","timestamp":1770996368493,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2511,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.virol.2006.05.010","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T18:40:18Z","timestamp":1152211218000},"page":"344-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Rabies virus glycoprotein as a carrier for anthrax protective antigen"],"prefix":"10.1016","volume":"353","author":[{"given":"Mary Ellen","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Koser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Siler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"McGettigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger J.","family":"Pomerantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Dietzschold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias J.","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.virol.2006.05.010_bib1","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/IAI.73.6.3408-3414.2005","article-title":"Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines","volume":"73","author":"Aulinger","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virol.2006.05.010_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1034\/j.1600-065X.2000.00606.x","article-title":"A two-phase model of B-cell activation","volume":"176","author":"Baumgarth","year":"2000","journal-title":"Immunol. Rev."},{"issue":"31","key":"10.1016\/j.virol.2006.05.010_bib3","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1016\/S0264-410X(01)00197-9","article-title":"Passive transfer of protection against Bacillus anthracis infection in a murine model","volume":"19","author":"Beedham","year":"2001","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.virol.2006.05.010_bib4","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2004.10.014","article-title":"Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants","volume":"23","author":"Berthold","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2006.05.010_bib5","series-title":"Anthrax Vaccine Adsorbed (Biothrax\u2122) Insert","author":"Bioport","year":"2002"},{"issue":"6860","key":"10.1016\/j.virol.2006.05.010_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"issue":"Pt. 6","key":"10.1016\/j.virol.2006.05.010_bib7","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1099\/0022-1317-70-6-1513","article-title":"Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein","volume":"70","author":"Bunschoten","year":"1989","journal-title":"J. Gen. Virol."},{"issue":"19","key":"10.1016\/j.virol.2006.05.010_bib8","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.vaccine.2003.11.064","article-title":"Pluronic F127-based systemic vaccine delivery systems","volume":"22","author":"Coeshott","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.virol.2006.05.010_bib9","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1083\/jcb.105.5.1957","article-title":"Role for adenosine triphosphate in regulating the assembly and transport of vesicular stomatitis virus G protein trimers","volume":"105","author":"Doms","year":"1987","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.virol.2006.05.010_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1083\/jcb.107.1.89","article-title":"Differential effects of mutations in three domains on folding, quaternary structure, and intracellular transport of vesicular stomatitis virus G protein","volume":"107","author":"Doms","year":"1988","journal-title":"J. Cell Biol."},{"issue":"Pt. 9","key":"10.1016\/j.virol.2006.05.010_bib11","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1099\/0022-1317-77-9-2001","article-title":"Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus","volume":"77","author":"Eckhart","year":"1996","journal-title":"J. Gen. Virol."},{"issue":"5556","key":"10.1016\/j.virol.2006.05.010_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.295.5556.777a","article-title":"Anthrax. \u2018Borrowed immunity\u2019 may save future victims","volume":"295","author":"Enserink","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.virol.2006.05.010_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/eji.1830210102","article-title":"T helper cell epitope of rabies virus nucleoprotein defined by tri- and tetrapeptides","volume":"21","author":"Ertl","year":"1991","journal-title":"Eur. J. Immunol."},{"issue":"Pt. 5","key":"10.1016\/j.virol.2006.05.010_bib14","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1099\/vir.0.80844-0","article-title":"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies","volume":"86","author":"Faber","year":"2005","journal-title":"J. Gen. Virol."},{"issue":"10","key":"10.1016\/j.virol.2006.05.010_bib15","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1084\/jem.185.10.1785","article-title":"Role of repetitive antigen patterns for induction of antibodies against antibodies","volume":"185","author":"Fehr","year":"1997","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.virol.2006.05.010_bib16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nm0898-945","article-title":"T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses","volume":"4","author":"Fehr","year":"1998","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.virol.2006.05.010_bib17","first-page":"506","article-title":"Development of anthrax DNA vaccines","volume":"6","author":"Ferrari","year":"2004","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"1","key":"10.1016\/j.virol.2006.05.010_bib18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/viro.1993.1261","article-title":"Mechanisms of rabies virus neutralization","volume":"194","author":"Flamand","year":"1993","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virol.2006.05.010_bib19","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/IAI.70.4.2022-2028.2002","article-title":"Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.virol.2006.05.010_bib20","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect. Immun."},{"issue":"26","key":"10.1016\/j.virol.2006.05.010_bib21","doi-asserted-by":"crossref","first-page":"14680","DOI":"10.1073\/pnas.011510698","article-title":"A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection","volume":"97","author":"Foley","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.virol.2006.05.010_bib22","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1073\/pnas.83.21.8122","article-title":"Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase","volume":"83","author":"Fuerst","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.virol.2006.05.010_bib23","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1128\/IAI.72.12.7096-7106.2004","article-title":"Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA","volume":"72","author":"Galen","year":"2004","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.virol.2006.05.010_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0042-6822(92)90465-2","article-title":"Rabies virus glycoprotein is a trimer","volume":"187","author":"Gaudin","year":"1992","journal-title":"Virology"},{"issue":"13\u201314","key":"10.1016\/j.virol.2006.05.010_bib25","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0264-410X(98)00447-2","article-title":"Rabies\u2014risk of exposure and current trends in prevention of human cases","volume":"17","author":"Haupt","year":"1999","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.virol.2006.05.010_bib26","doi-asserted-by":"crossref","first-page":"10908","DOI":"10.1073\/pnas.91.23.10908","article-title":"Rabies ribonucleocapsid as an oral immunogen and immunological enhancer","volume":"91","author":"Hooper","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.virol.2006.05.010_bib27","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/iai.59.6.1961-1965.1991","article-title":"Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals","volume":"59","author":"Iacono-Connors","year":"1991","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.virol.2006.05.010_bib28","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/iai.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins","year":"1992","journal-title":"Infect. Immun."},{"issue":"11\u201312","key":"10.1016\/j.virol.2006.05.010_bib29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.virol.2006.05.010_bib30","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1002\/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J","article-title":"Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation","volume":"32","author":"Jegerlehner","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.virol.2006.05.010_bib31","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3201\/eid0810.020353","article-title":"Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings","volume":"8","author":"Jernigan","year":"2002","journal-title":"Emerging Infect. Dis."},{"issue":"2","key":"10.1016\/j.virol.2006.05.010_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ymthe.2004.10.018","article-title":"Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody","volume":"11","author":"Kasuya","year":"2005","journal-title":"Molec. Ther.: J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.virol.2006.05.010_bib33","series-title":"The International Conference on Emerging Infectious Diseases (ICEID)","author":"Keyserling","year":"2004"},{"issue":"2","key":"10.1016\/j.virol.2006.05.010_bib34","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/IAI.70.2.544-550.2002","article-title":"Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization","volume":"70","author":"Kobiler","year":"2002","journal-title":"Infect. Immun."},{"issue":"25","key":"10.1016\/j.virol.2006.05.010_bib35","doi-asserted-by":"crossref","first-page":"9405","DOI":"10.1073\/pnas.0403060101","article-title":"Rabies virus nucleoprotein as a carrier for foreign antigens","volume":"101","author":"Koser","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.virol.2006.05.010_bib36","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/IAI.71.3.1491-1496.2003","article-title":"Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge","volume":"71","author":"Lee","year":"2003","journal-title":"Infect. Immun."},{"issue":"15","key":"10.1016\/j.virol.2006.05.010_bib37","doi-asserted-by":"crossref","first-page":"10003","DOI":"10.1128\/JVI.79.15.10003-10012.2005","article-title":"Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity","volume":"79","author":"Li","year":"2005","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virol.2006.05.010_bib38","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/iai.65.12.5171-5175.1997","article-title":"Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs","volume":"65","author":"Little","year":"1997","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.virol.2006.05.010_bib39","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.4049\/jimmunol.133.5.2748","article-title":"T cell responses to cleaved rabies virus glycoprotein and to synthetic peptides","volume":"133","author":"Macfarlan","year":"1984","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.virol.2006.05.010_bib40","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1128\/IAI.72.6.3471-3477.2004","article-title":"Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine","volume":"72","author":"Marcus","year":"2004","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.virol.2006.05.010_bib41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt0602-597","article-title":"Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity","volume":"20","author":"Maynard","year":"2002","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.virol.2006.05.010_bib42","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0264-410X(97)00268-5","article-title":"Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers","volume":"16","author":"McBride","year":"1998","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.virol.2006.05.010_bib43","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1128\/JVI.75.9.4430-4434.2001","article-title":"Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates","volume":"75","author":"McGettigan","year":"2001","journal-title":"J. Virol."},{"issue":"18","key":"10.1016\/j.virol.2006.05.010_bib44","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1128\/JVI.75.18.8724-8732.2001","article-title":"Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector","volume":"75","author":"McGettigan","year":"2001","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2006.05.010_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/1570162033485320","article-title":"Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases","volume":"1","author":"McKenna","year":"2003","journal-title":"Curr. HIV Res."},{"issue":"24","key":"10.1016\/j.virol.2006.05.010_bib46","doi-asserted-by":"crossref","first-page":"13455","DOI":"10.1128\/JVI.78.24.13455-13459.2004","article-title":"Immunogenicity study of glycoprotein-deficient rabies virus expressing simian\/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque","volume":"78","author":"McKenna","year":"2004","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.virol.2006.05.010_bib47","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.1016\/S0021-9258(18)42016-9","article-title":"Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen","volume":"267","author":"Molloy","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.virol.2006.05.010_bib48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0022-1759(01)00353-2","article-title":"High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector","volume":"252","author":"Morimoto","year":"2001","journal-title":"J. Immunol. Methods"},{"issue":"32","key":"10.1016\/j.virol.2006.05.010_bib49","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.virol.2006.05.010_bib50","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/clinids\/2.3.433","article-title":"Rabies vaccine prepared in human cell cultures: progress and perspectives","volume":"2","author":"Plotkin","year":"1980","journal-title":"Rev. Infect. Dis."},{"issue":"19","key":"10.1016\/j.virol.2006.05.010_bib51","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.1834478100","article-title":"A dually active anthrax vaccine that confers protection against both bacilli and toxins","volume":"100","author":"Rhie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.virol.2006.05.010_bib52","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1128\/JVI.74.5.2239-2246.2000","article-title":"The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly","volume":"74","author":"Robison","year":"2000","journal-title":"J. Virol."},{"issue":"7002","key":"10.1016\/j.virol.2006.05.010_bib53","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02763","article-title":"Crystal structure of a complex between anthrax toxin and its host cell receptor","volume":"430","author":"Santelli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.virol.2006.05.010_bib54","first-page":"5","article-title":"Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed","volume":"vol. 2","author":"Sawada-Hirai","year":"2004"},{"issue":"Suppl. 4","key":"10.1016\/j.virol.2006.05.010_bib55","doi-asserted-by":"crossref","first-page":"S654","DOI":"10.1093\/clinids\/10.Supplement_4.S654","article-title":"Current oral rabies vaccination in Europe: an interim balance","volume":"10","author":"Schneider","year":"1988","journal-title":"Rev. Infect. Dis."},{"issue":"7","key":"10.1016\/j.virol.2006.05.010_bib56","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1073\/pnas.97.7.3544","article-title":"Recombinant rabies virus as potential live-viral vaccines for HIV-1","volume":"97","author":"Schnell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.virol.2006.05.010_bib57","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Scobie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5517","key":"10.1016\/j.virol.2006.05.010_bib58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1126\/science.109563","article-title":"Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax","volume":"292","author":"Sellman","year":"2001","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.virol.2006.05.010_bib59","first-page":"919","article-title":"Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum","volume":"11","author":"Semenova","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"15","key":"10.1016\/j.virol.2006.05.010_bib60","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1016\/S0021-9258(19)50073-4","article-title":"N-linked glycosylation of rabies virus glycoprotein. Individual sequons differ in their glycosylation efficiencies and influence on cell surface expression","volume":"267","author":"Shakin-Eshleman","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.virol.2006.05.010_bib61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/viro.2001.1212","article-title":"Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines","volume":"292","author":"Siler","year":"2002","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virol.2006.05.010_bib62","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0736-4679(03)00079-9","article-title":"The history of anthrax","volume":"24","author":"Sternbach","year":"2003","journal-title":"J. Emerg.Med."},{"issue":"17","key":"10.1016\/j.virol.2006.05.010_bib63","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1089\/104303403322542310","article-title":"Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen","volume":"14","author":"Tan","year":"2003","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.virol.2006.05.010_bib64","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/clin.1994.1088","article-title":"Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man","volume":"71","author":"Thraenhart","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.virol.2006.05.010_bib65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00001432-200004000-00004","article-title":"Current status of immunization against anthrax: old vaccines may be here to stay for a while","volume":"13","author":"Turnbull","year":"2000","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virol.2006.05.010_bib66","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0378-1119(88)90439-8","article-title":"Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis","volume":"69","author":"Welkos","year":"1988","journal-title":"Gene"},{"issue":"Pt. 6","key":"10.1016\/j.virol.2006.05.010_bib67","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.virol.2006.05.010_bib68","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0042-6822(91)90539-N","article-title":"Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein","volume":"185","author":"Whitt","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.05.010_bib69","series-title":"The Natural History of Rabies","first-page":"31","article-title":"The chemical composition and molecular structure of rabies viruses","author":"Wunner","year":"1991"},{"key":"10.1016\/j.virol.2006.05.010_bib70","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.21.120601.141045","article-title":"On natural and artificial vaccinations","volume":"21","author":"Zinkernagel","year":"2003","journal-title":"Ann. Rev. Immunol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268220600331X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268220600331X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:45:01Z","timestamp":1758584701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268220600331X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S004268220600331X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2006.05.010","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rabies virus glycoprotein as a carrier for anthrax protective antigen","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2006.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}